Although its role in the context of metabolic diseases is still elusive, ANGPTL4 plasma levels have been reported to be significantly higher in patients with metabolic syndrome and were predictive for future cardiovascular events [26]. This evidence concerns the gene ANGPTL4 and Other metabolic disease.